Patents by Inventor Robin Enever

Robin Enever has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUGAR-COATING PROCESS AND BAFFLES THEREFOR
    Publication number: 20080286439
    Abstract: This invention provides baffles (10) for use in coating pans (50) within coating apparatus, and methods of manufacturing the baffles (10). The invention further provides methods of coating pharmaceutical formulations using the baffles (10) and coating pans (50) of the present invention.
    Type: Application
    Filed: November 5, 2007
    Publication date: November 20, 2008
    Applicant: WYETH
    Inventors: Xiuying LIU, Nizamuddin BAKSH, Sheetal KULKARNI, John KRESEVIC, Robin ENEVER
  • ESTROGEN/SERM AND ESTROGEN/PROGESTIN BI-LAYER TABLETS
    Publication number: 20080175905
    Abstract: The present invention is directed to bi-layer tablets comprising at least one estrogen in a first layer and a therapeutic agent in a second layer, and processes for their preparation.
    Type: Application
    Filed: November 28, 2007
    Publication date: July 24, 2008
    Applicant: Wyeth
    Inventors: Xiuying Liu, John Kresevic, Nizamuddin Baksh, Robin Enever
  • TABLET-IN-TABLET COMPOSITIONS
    Publication number: 20080175908
    Abstract: The present invention is directed to tablet-in-tablet compositions comprising one or more estrogens in a first layer and a therapeutic agent in a second layer, and processes for their preparation
    Type: Application
    Filed: January 11, 2008
    Publication date: July 24, 2008
    Applicant: Wyeth
    Inventors: Xiuying Liu, John Kresevic, Nizamuddin Baksh, Robin Enever
  • SUGAR COATINGS AND METHODS THEREFOR
    Publication number: 20080107780
    Abstract: The invention provides sugar-containing compositions suitable for use in coating solid preparations such as tablets, pills, granules and grains. Methods of using such coatings are provided, as are solid dosage forms coated with the compositions. In some embodiments, the methods provide sugar coated tablets comprising conjugated estrogens, and a progestin, for example medroxyprogesterone acetate.
    Type: Application
    Filed: November 5, 2007
    Publication date: May 8, 2008
    Applicant: WYETH
    Inventors: John KRESEVIC, Sheetal KULKARNI, Xiuying LIU, Nizamuddin BAKSH, Robin ENEVER
  • Ethers of 7-desmethlrapamycin
    Patent number: 6440991
    Abstract: This invention provides ethers of 7-desmethylrapamycin which are useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: August 27, 2002
    Assignee: Wyeth
    Inventors: Tianmin Zhu, Robin Enever
  • Hydroxyesters of 7-desmethylrapamycin
    Patent number: 6399626
    Abstract: This invention provides hydroxyesters of 7-desmethylrapamycin which are useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: June 4, 2002
    Assignee: Wyeth
    Inventors: Tianmin Zhu, Robin Enever
  • Ethers of 7-desmethylrapamycin
    Publication number: 20020061905
    Abstract: This invention provides ethers of 7-desmethylrapamycin which are useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.
    Type: Application
    Filed: September 19, 2001
    Publication date: May 23, 2002
    Applicant: American Home Products Corporation
    Inventors: Tianmin Zhu, Robin Enever
  • Hydroxyesters of 7-desmethylrapamycin
    Publication number: 20020061904
    Abstract: This invention provides hydroxyesters of 7-desmethylrapamycin which are useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.
    Type: Application
    Filed: September 19, 2001
    Publication date: May 23, 2002
    Inventors: Tianmin Zhu, Robin Enever